Does AFATINIB Cause Skin lesion? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Skin lesion have been filed in association with AFATINIB (Gilotrif). This represents 0.4% of all adverse event reports for AFATINIB.
23
Reports of Skin lesion with AFATINIB
0.4%
of all AFATINIB reports
3
Deaths
9
Hospitalizations
How Dangerous Is Skin lesion From AFATINIB?
Of the 23 reports, 3 (13.0%) resulted in death, 9 (39.1%) required hospitalization.
Is Skin lesion Listed in the Official Label?
Yes, Skin lesion is listed as a known adverse reaction in the official FDA drug label for AFATINIB.
What Other Side Effects Does AFATINIB Cause?
Diarrhoea (2,001)
Malignant neoplasm progression (1,622)
Rash (808)
Stomatitis (468)
Death (443)
Nausea (430)
Decreased appetite (412)
Vomiting (381)
Paronychia (344)
Dehydration (323)
What Other Drugs Cause Skin lesion?
SECUKINUMAB (1,909)
ADALIMUMAB (1,507)
METHOTREXATE (1,237)
DUPILUMAB (685)
ETANERCEPT (647)
PREDNISONE (617)
TOFACITINIB (478)
INFLIXIMAB (474)
CYCLOSPORINE (380)
LENALIDOMIDE (369)
Which AFATINIB Alternatives Have Lower Skin lesion Risk?
AFATINIB vs AFINITOR
AFATINIB vs AFLIBERCEPT
AFATINIB vs AGALSIDASE ALFA
AFATINIB vs AGALSIDASE BETA
AFATINIB vs AGOMELATINE